ARTICLE | Company News
Depomed, Elan deal
January 31, 2000 8:00 AM UTC
The companies completed the formation of a joint venture to develop their respective gastric retention oral drug delivery technologies for undisclosed therapeutic areas (see BioCentury, Dec. 6, 1999)....